12967_2016_774_MOESM1_ESM.tif (48.95 kB)

MOESM1 of Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction

figure

posted on 2016-01-20, 05:00 authored by Roseanne Raphael, Diana Purushotham, Courtney Gastonguay, Marla Chesnik, Wai-Meng Kwok, Hsiang-En Wu, Sanjiv Shah, Shama Mirza, Jennifer Strande

Additional file 1: Figure S1. Â Flow cytometry to assess platelet activation. Purified platelet samples were incubated with fluorescently labeled antibodies against CD62P and CD41 and subject to flow cytometry. Platelets positive for CD41Â +Â but negative for CD62P are non-activated. CD62P positive platelets are activated.

Funding

Clinical and Translational Science Award (CTSI) program of the National Center for Research Resources, National Institutes of Health

History

Usage metrics

Keywords

Platelet proteome Heart failure with preserved ejection fraction Inflammation S100A8 Induced pluripotent stem cell-derived cardiomyocytes

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM